¬â¬Ö¬Þ¬à¬ß¬ä ¬Ü¬à¬ä¬ä¬Ö¬Õ¬Ø¬Ñ | ||||||||||
ErcomtExcub | 2021-09-05 | 148 | ||||||||
¬Ü¬Ñ¬á¬Ú¬ä¬Ñ¬Ý¬î¬ß¬í¬Û ¬â¬Ö¬Þ¬à¬ß¬ä ¬Ü¬Ó¬Ñ¬â¬ä¬Ú¬â Tegs: ¬Ü¬Ñ¬á¬Ú¬ä¬Ñ¬Ý¬î¬ß¬í¬Û ¬â¬Ö¬Þ¬à¬ß¬ä ¬Ü¬Ó¬Ñ¬â¬ä¬Ú¬â ¬Ó ¬Þ¬à¬ã¬Ü¬Ó¬Ö https://www.remontstroyka.ru/capital.php ¬Õ¬Ú¬Ù¬Ñ¬Û¬ß¬Ö¬â¬ã¬Ü¬Ú¬Û ¬â¬Ö¬Þ¬à¬ß¬ä ¬Ü¬Ó¬Ñ¬â¬ä¬Ú¬â ¬á¬à¬Õ ¬Ü¬Ý¬ð¬é ¬â¬Ö¬Þ¬à¬ß¬ä ¬Ù¬Ñ¬Ô¬à¬â¬à¬Õ¬ß¬à¬Ô¬à ¬Õ¬à¬Þ¬Ñ ¬â¬Ö¬Þ¬à¬ß¬ä ¬Ù¬Ñ¬Ô¬à¬â¬à¬Õ¬ß¬à¬Ô¬à ¬Õ¬à¬Þ¬Ñ ¬á¬à¬Õ ¬Ü¬Ý¬ð¬é |
18586 | endostatin murine, recombinant ¬Ü¬å¬á¬Ú¬ä¬î ¬à¬ß¬Ý¬Ñ... | LavillEvat | 2024-04-03 | 7 | |
18585 | anti-histone deacetylase 1 (hdac1) anti& ¬Ü¬å¬á¬Ú¬ä... | LavillEvat | 2024-03-31 | 8 | |
18584 | First revalidation, dilatation ptosis accountability... | axojaqeera | 2024-01-05 | 34 | |
18583 | L, documentation rotational, expressed accountabilit... | axojaqeera | 2024-01-05 | 34 | |
18582 | ¬Ü¬à¬Ý¬à¬ß¬Ü¬Ñ ¬Õ¬Ý¬ñ ¬Ó¬ï¬Ø¬ç caprisil c18 5 ¬Þ¬Ü¬Þ... | LavillEvat | 2023-10-28 | 68 | |
18581 | pyrex(r) vista(tm) volumetric pipette, & ¬Ü¬å¬á¬Ú¬ä... | LavillEvat | 2023-10-18 | 62 | |
18580 | 5-chloro-2-[(4-fluorobenzyl)oxy]benzoyl chloride †... | LavillEvat | 2023-10-13 | 68 | |
18579 | human gabrr1 gene orf cdna clone expression plasmid ... | LavillEvat | 2023-10-07 | 72 | |
18578 | Consider rehabilitating total symptom memory, append... | eshuhia | 2023-09-22 | 79 | |
18577 | Consider case-control crescent higher, health-relate... | eshuhia | 2023-09-22 | 72 | |
1 2 3 4 5 6 7 8 9 10 |